Peptides BiosciencesRetatrutide 10mg
Retatrutide is an advanced investigational peptide designed to support weight management and metabolic health. It works by targeting three key hormone receptors involved in appetite control, glucose regulation, and energy expenditure: GLP-1, GIP, and glucagon receptors. Early clinical studies have s Research use only — not for human or veterinary use.
Tap I use this — we'll set up your dose, reminders & journey in 30 seconds.
Retatrutide: The Next Generation of Metabolic and Weight Management Research What Is Retatrutide? Retatrutide is an investigational peptide therapy currently being studied for its potential role in weight management, metabolic health, and glucose regulation. Developed as a next-generation multi-receptor agonist, Retatrutide is designed to target three important hormone pathways involved in appetite control, energy expenditure, and blood sugar balance. Unlike earlier therapies that focus on a single receptor, Retatrutide works by activating: GLP-1 (Glucagon-Like Peptide-1) receptors GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors Glucagon receptors This triple-action mechanism has generated significant interest within the scientific and medical communities due to its potential to support substantial weight reduction and improved metabolic function. How Retatrutide Works Retatrutide is often described as a “triple agonist” because it simultaneously stimulates three hormone systems that influence how the body regulates hunger, calories, and blood glucose. GLP-1 Receptor Activation GLP-1 receptor stimulation may help: Reduce appetite Slow gastric emptying Improve feelings of fullness Support healthier eating behaviors GIP Receptor Activation GIP signaling is associated with: Enhanced insulin response Better glucose handling Improved metabolic efficiency Glucagon Receptor Activation The glucagon component may contribute t
- Peptide
- Retatrutide
- Strength
- 10 mg
- Package
- 10mg × 10 vials
- Form
- vial
- Concentration
- 10mg × 10 vials
